GENZYME - THE KING OF THE BIOTECHS Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GENZYME - THE KING OF THE BIOTECHS

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jeffrey Silver who wrote (357)	11/17/1998 11:50:00 PM
From: Charles Holewinski	Read Replies (1) of 410

That's exactly my point. I am holding 200 shares of GENZ and now I also have 21 shares of their latest spin off. Since I have these shares in an account at a discount broker it will only cost me $12 to sell them but it does not seem that these spun off shares are going to be a great hold. Since most of us will only have a few such shares we will probably sell them which will do nothing but lower their price at first. Now what is going to happen to any earnings this drug/treatment will bring to GENZ? Will I as a holder of 21 shares get my share of the profits? No I don't think so. All of the earnings are going to be somehow moved into GENZ is what I am thinking. If this is such a great financial method why doesn't the big boys such as Merck or Bristol Myers employ it? I happen to think that GENZ has a great future in developing some of the most remarkable medical products which we will see in the 21st Century and of course as a stock holder I am hoping to participate in the financial rewards such products will bring, but with each item being spun off into another stock issue I am concluding such participation will be null.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next